Natalie Moshayedi

Gut microbiome and pancreatic cancer cachexia: An evolving relationship

N. Bhowmick, S. Devkota, Jonathan P. Jacobs, 2022, World journal of gastrointestinal oncology.

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

M. Tighiouart, Julianne C. Yang, J. Gong, 2022, Scientific Reports.

Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis.

S. Pandol, A. Hendifar, N. Nissen, 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

R. Patel, J. Gong, R. Tuli, 2022, Oncotarget.

Exceptional Response to Erda fi tinib in FGFR2 -Mutated Metastatic Pancreatic Ductal Adenocarcinoma

J. Gong, J. Glaspy, A. Hendifar, 2022 .

Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer

Sarah J. Parker, N. Tatonetti, N. Bhowmick, 2023, Cancers.

Exceptional Response to Erdafitinib in FGFR2-Mutated Metastatic Pancreatic Ductal Adenocarcinoma.

J. Gong, J. Glaspy, A. Hendifar, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer

Kevin M. Waters, A. Gangi, J. Gong, 2021, JAMA network open.